Phenotypic high-throughput screening elucidates target pathway in breast cancer stem cell-like cells

Journal of Biomolecular Screening

Volumn 17, Issue 9, 2012, Pages 1204-1210

  Carmody, Leigh C ^a   Germain, Andrew R ^a   Verplank, Lynn ^a   Nag, Partha P ^a   Muñoz, Benito ^a   Perez, Jose R ^a   Palmer, Michelle ^a  

^a BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

breast cancer; cancer stem cells; MLPCN

Indexed keywords

HYDRAZONE DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER SCREENING; CANCER STEM CELL; CELL DIFFERENTIATION; CELL GROWTH; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; MOLECULAR LIBRARY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY CONTROL; TARGET CELL; TISSUE CULTURE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION PROFILING; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; HYDRAZONES; INHIBITORY CONCENTRATION 50; NEOPLASTIC STEM CELLS; NF-KAPPA B; PYRROLES; SMALL MOLECULE LIBRARIES;

EID: 84866371806     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057112458317     Document Type: Article

References (13)

1. Diehn M., Bhattacharya R., Botstein D., Brown P. O. Genome-Scale Identification of Membrane-Associated Human mRNAs. PLoS Genet. 2006 ; 2: e11
2. Diehn M., Cho R. W., Clarke M. F. Therapeutic Implications of the Cancer Stem Cell Hypothesis. Semin. Radiat. Oncol. 2009 ; 19: 78-86
3. Eyler C. E., Rich J. N. Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and Angiogenesis. J. Clin. Oncol. 2008 ; 26: 2839-2845
4. Gupta P. B., Onder T. T., Jiang G., Tao K., Kuperwasser C., Weinberg R. A., Lander E. S. Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening. Cell. 2009 ; 138: 645-659
5. Carmody L. C., Germain A., Morgan B., Burhlage S., VerPlank L., Munoz B., Feng Y., Gupta P. B., Lander E. S., Palmer M., et al Identification of Selective Breast Cancer Stem Cell Inhibitors, Probe 1. Bethesda (MD): National Center for Biotechnology Information (US) ;
6. Dontu G., Al-Hajj M., Abdallah W. M., Clarke M. F., Wicha M. S. Stem Cells in Normal Breast Development and Breast Cancer. Cell Prolif. 2003 ; 36: 59-72
7. Gupta P. B., Chaffer C. L., Weinberg R. A. Cancer Stem Cells: Mirage or Reality?. Nat. Med. 2009 ; 15: 1010-1012
8. Mani S. A., Guo W., Liao M. J., Eaton E. N., Ayyanan A., Zhou A. Y., Brooks M., Reinhard F., Zhang C. C., Shipitsin M., et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells. Cell. 2008 ; 133: 704-715
9. Germain A. R., Carmody L. C., Morgan B., Fernandez C., Forbeck E., Lewis T. A., Nag P. P., Ting A., VerPlank L., Feng Y., et al. Identification of a Selective Small Molecule Inhibitor of Breast Cancer Stem Cells. Bioorg. Med. Chem. Lett. 2012 ; 22: 3571-3574
10. Gupta P. B., Fillmore C. M., Jiang G., Shapira S. D., Tao K., Kuperwasser C., Lander E. S. Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells. Cell. 2011 ; 146: 633-644
11. Wennemers M., Bussink J., Grebenchtchikov N., Sweep F. C., Span P. N. TRIB3 Protein Denotes a Good Prognosis in Breast Cancer Patients and Is Associated with Hypoxia Sensitivity. Radiother. Oncol. 2011 ; 101: 198-202
12. Kakarala M., Brenner D. E., Korkaya H., Cheng C., Tazi K., Ginestier C., Liu S., Dontu G., Wicha M. S. Targeting Breast Stem Cells with the Cancer Preventive Compounds Curcumin and Piperine. Breast Cancer Res. Treat. 2010 ; 122: 777-785
13. Zhou J., Zhang H., Gu P., Bai J., Margolick J. B., Zhang Y. NF-kappaB Pathway Inhibitors Preferentially Inhibit Breast Cancer Stem-Like Cells. Breast Cancer Res. Treat. 2008 ; 111: 419-427